Fintel reports that on May 8, 2026, Benchmark downgraded their outlook for Cross Country Healthcare (NasdaqGS:CCRN) from Buy to Hold. Analyst Price Forecast Suggests 9.57% Downside As of April 28, ...

Cross Country (CCRN) delivered earnings and revenue surprises of +36.84% and +2.34%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Fintel reports that on May 7, 2026, Wedbush downgraded their outlook for Cross Country Healthcare (NasdaqGS:CCRN) from Outperform to Neutral. Analyst Price Forecast Suggests 17.71% Upside As of April ...

Cross Country Healthcare is being acquired by P/E firm Knox Lane for $13.25 per share in an all-cash transaction. Knox Lane has a healthcare staffing business in its portfolio, but the merger involves ...

While the top- and bottom-line numbers for Cross Country (CCRN) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cross ...

Cross Country Healthcare Inc. (CCRN) on Thursday reported a loss of $4.3 million in its first quarter. On a per-share basis, the Boca ...

Cross Country Healthcare is back in focus after analysts reset price targets into the US$10 to US$14 range, while modelled fair value sits at US$11.67 per share. The new targets are being framed ...

Stock futures were cautious on Thursday amid optimism over a potential diplomatic breakthrough in the Middle East. Investors ...

Cross Country Healthcare (NASDAQ: CCRN), a market-leading provider of workforce solutions and tech-enabled staffing, recruitment and advisory ...